What is Simulations Plus?
We have positioned ourselves as leaders in ADMET property prediction, physiologically-based pharmacokinetics (PBPK) modeling, pharmacometrics, and quantitative systems pharmacology/toxicology, a recognition earned through the successes of our clients who collaborate with us. With more than twenty years of experience, our talented team specializes in converting intricate scientific ideas into user-friendly software solutions, in addition to providing tailored consulting services that enhance drug discovery efforts, clinical development research, and the regulatory submission process. Our commitment to ensuring our clients' achievements fuels our ongoing advancement and creativity in these vital sectors, reinforcing our reputation in the industry. By continually adapting to the evolving landscape of pharmaceutical science, we aim to further support our partners in achieving their goals.
Integrations
No integrations listed.
Similar Software to Simulations Plus
RegDesk stands out as the leading RIMS platform enhanced by AI, tailored specifically for Medical Device, Pharmaceutical, and IVD companies.
• Our unique Regulatory Intelligence encompasses data from over 120 countries, all presented in a uniform format, and includes timely alerts regarding regulatory updates.
• With our AI-driven Application Builder, regulatory affairs teams can efficiently create and submit global applications in a fraction of the usual time.
• The Change Assessment feature enables RA teams to evaluate the implications of changes on current products and determine the necessary actions.
• Our Distributor Collaboration tool facilitates smooth workflows for communication and document sharing with external partners.
• The Standards Management function simplifies the process for RA teams to locate and oversee both international and country-specific standards.
• Additionally, our Tracking & Reporting capability empowers teams to monitor regulatory initiatives worldwide, receive notifications for renewals, and quickly compile reports on key performance indicators.
To learn more about our offerings, please explore our website.
Learn more
Implementing a career development initiative that swiftly guides employees along their individual career trajectories towards new objectives places them at the center of your learning and development strategy. By incorporating a range of micro-learning experiences along with career coaching and mentoring, you can empower your top talent to find greater purpose and engagement in their work. This initiative offers distinctive learning and development opportunities through a unique blend of personalized services paired with advanced technological tools. Furthermore, a holistic approach to career advancement and mobility sheds light on market trends and aligns employees’ skills with their desired roles. Career coaches play a vital role in helping employees navigate their career paths and create tailored learning plans designed to fulfill their professional aspirations and skill enhancement needs. Ultimately, investing in your employees’ growth fosters a more motivated and skilled workforce, benefiting both the individuals and the organization as a whole.
Learn more
ADME Suite
Forecasting the absorption, distribution, metabolism, and excretion (ADME) characteristics based on chemical structure is crucial. This set of precise calculations pertaining to pharmacokinetic properties is beneficial for facilitating high-throughput screening of various libraries. Additionally, it offers valuable insights into pharmacological impacts, aiding in the assurance of human safety for the products being developed. Such predictive modeling can significantly enhance the efficiency of drug discovery processes.
Learn more
BenevolentAI
BenevolentAI is a groundbreaking platform that harnesses the power of artificial intelligence and advanced scientific methodologies to improve the drug discovery process, particularly for challenging diseases, by swiftly analyzing and interpreting vast amounts of biomedical data to generate practical insights more quickly than traditional methods. Through its distinctive Benevolent Platform, the company adeptly combines both structured and unstructured biomedical data—including literature, genomic information, clinical records, and multi-omics—into a comprehensive knowledge graph. This sophisticated structure enables researchers to explore biological systems, develop testable hypotheses, discover new drug targets, and design potential drug candidates with greater assurance and lower chances of failure, thereby revolutionizing the field of medicine development. By pioneering such innovative strategies, BenevolentAI not only enhances the efficiency of pharmaceutical research but also significantly impacts the future of healthcare and treatment options. As a result, BenevolentAI is positioned as a leader in ushering in a transformative phase within the pharmaceutical sector.
Learn more
Screenshots and Video
Company Facts
Company Name:
Simulations Plus
Date Founded:
1996
Company Location:
United States
Company Website:
www.simulations-plus.com
Product Details
Deployment
SaaS
Training Options
Documentation Hub
Webinars
Support
Web-Based Support
Product Details
Target Company Sizes
Individual
1-10
11-50
51-200
201-500
501-1000
1001-5000
5001-10000
10001+
Target Organization Types
Mid Size Business
Small Business
Enterprise
Freelance
Nonprofit
Government
Startup
Supported Languages
English